This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
29 Dec 2015 | Global | Technology Research
Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology
Strategic Partnerships that are Transforming the Healthcare Industry
In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...
$4,950.00 -
18 Dec 2015 | Global | Technology Alert
Medical Imaging—Toward Deep-Rooted Cancer Cell Imaging - Medical and Diagnostic Imaging Technology
This issue profiles cancer cell imaging technologies.
$950.00 -
11 Dec 2015 | Global | Technology Alert
Futuretech TechVision Opportunity Engine--Therapeutics Devices (Non-Drug) for Sleep Apnea
This issue profiles technology advances and trends for the treatment of sleep apnea.
$750.00 -
11 Dec 2015 | South Asia, Middle East & North Africa | Market Research
Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later
The Lifting of Nuclear Sanctions on Iran will open a Plethora of Opportunities in the Medical Tourism and Pharmaceutical Sectors
Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacity. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $415.3 billion in 2014. The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial t...
$1,500.00 -
08 Dec 2015 | Global | Market Research
Analysis of the Global Fibrinogen Market and Product Pipeline
Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth
The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed ...
$6,000.00 -
27 Nov 2015 | Global | Technology Alert
Medical and Diagnostic Imaging Technology TechVision Opportunity Engine--Innovating toward Enhanced Medical Imaging Platforms
This edition profiles innovations aimed at producing enhanced medical imaging platforms.
$950.00 -
30 Oct 2015 | Global | Technology Alert
Medical And Diagnostic Imaging Technology--Medical Imaging Leading the Way to Better Diagnosis
This alert profiles medical imaging technologies that enable better diagnosis.
$950.00 -
30 Sep 2015 | Global | Market Research
A Product and Pipeline Analysis of the Global Immunoglobulin Market
Trends in Communicable and Non-Communicable Diseases Drug Pipeline
Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...
$4,950.00 -
29 Sep 2015 | Global | Technology Research
Advances in monoclonal antibody therapeutics
Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...
$4,950.00 -
29 Sep 2015 | Global | Market Research
Insights for CFOs betting on Intellectual Property
Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and greater convenience to patients. This research service evaluates ...
$4,950.00
